Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs ZYDUS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA ZYDUS LIFESCIENCES SANOFI INDIA/
ZYDUS LIFESCIENCES
 
P/E (TTM) x 29.8 33.9 87.9% View Chart
P/BV x 14.8 5.7 259.0% View Chart
Dividend Yield % 7.3 0.6 1,204.7%  

Financials

 SANOFI INDIA   ZYDUS LIFESCIENCES
EQUITY SHARE DATA
    SANOFI INDIA
Dec-22
ZYDUS LIFESCIENCES
Mar-23
SANOFI INDIA/
ZYDUS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs7,939495 1,604.0%   
Low Rs5,454319 1,707.6%   
Sales per share (Unadj.) Rs1,202.8170.3 706.3%  
Earnings per share (Unadj.) Rs269.519.8 1,362.5%  
Cash flow per share (Unadj.) Rs287.726.9 1,068.7%  
Dividends per share (Unadj.) Rs570.006.00 9,500.0%  
Avg Dividend yield %8.51.5 577.6%  
Book value per share (Unadj.) Rs527.0173.0 304.5%  
Shares outstanding (eoy) m23.031,012.20 2.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.62.4 232.9%   
Avg P/E ratio x24.920.6 120.7%  
P/CF ratio (eoy) x23.315.1 153.9%  
Price / Book Value ratio x12.72.4 540.1%  
Dividend payout %211.530.3 697.3%   
Avg Mkt Cap Rs m154,224412,144 37.4%   
No. of employees `000NANA-   
Total wages/salary Rs m4,05924,564 16.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m27,701172,374 16.1%  
Other income Rs m7304,746 15.4%   
Total revenues Rs m28,431177,120 16.1%   
Gross profit Rs m8,34929,677 28.1%  
Depreciation Rs m4197,227 5.8%   
Interest Rs m171,299 1.3%   
Profit before tax Rs m8,64325,897 33.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,4375,878 41.5%   
Profit after tax Rs m6,20620,019 31.0%  
Gross profit margin %30.117.2 175.1%  
Effective tax rate %28.222.7 124.2%   
Net profit margin %22.411.6 192.9%  
BALANCE SHEET DATA
Current assets Rs m36,121100,082 36.1%   
Current liabilities Rs m27,42555,267 49.6%   
Net working cap to sales %31.426.0 120.7%  
Current ratio x1.31.8 72.7%  
Inventory Days Days11750 232.0%  
Debtors Days Days1794 18.2%  
Net fixed assets Rs m12,148144,776 8.4%   
Share capital Rs m2301,012 22.7%   
"Free" reserves Rs m11,906174,146 6.8%   
Net worth Rs m12,136175,158 6.9%   
Long term debt Rs m00-   
Total assets Rs m48,279244,940 19.7%  
Interest coverage x509.420.9 2,433.2%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.7 81.5%   
Return on assets %12.98.7 148.1%  
Return on equity %51.111.4 447.4%  
Return on capital %71.415.5 459.6%  
Exports to sales %14.139.2 35.9%   
Imports to sales %14.611.9 122.3%   
Exports (fob) Rs m3,90467,577 5.8%   
Imports (cif) Rs m4,03720,544 19.6%   
Fx inflow Rs m3,90467,577 5.8%   
Fx outflow Rs m4,03720,544 19.6%   
Net fx Rs m-13347,033 -0.3%   
CASH FLOW
From Operations Rs m3,98726,888 14.8%  
From Investments Rs m6,50911,712 55.6%  
From Financial Activity Rs m-15,827-44,004 36.0%  
Net Cashflow Rs m-5,331-5,338 99.9%  

Share Holding

Indian Promoters % 0.0 75.0 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 27.1 18.0 150.5%  
FIIs % 6.3 5.0 126.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 25.0 158.3%  
Shareholders   62,870 306,495 20.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    SUPRIYA LIFESCIENCE     


More on Sanofi India vs Cadila Healthcare

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Sanofi India vs Cadila Healthcare Share Price Performance

Period Sanofi India Cadila Healthcare S&P BSE HEALTHCARE
1-Day 0.75% 0.68% 0.88%
1-Month -14.93% 9.12% -4.09%
1-Year 36.65% 108.16% 59.00%
3-Year CAGR -0.77% 33.12% 18.97%
5-Year CAGR 6.86% 23.90% 19.20%

* Compound Annual Growth Rate

Here are more details on the Sanofi India share price and the Cadila Healthcare share price.

Moving on to shareholding structures...

The promoters of Sanofi India hold a 60.4% stake in the company. In case of Cadila Healthcare the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Sanofi India and the shareholding pattern of Cadila Healthcare.

Finally, a word on dividends...

In the most recent financial year, Sanofi India paid a dividend of Rs 570.0 per share. This amounted to a Dividend Payout ratio of 211.5%.

Cadila Healthcare paid Rs 6.0, and its dividend payout ratio stood at 30.3%.

You may visit here to review the dividend history of Sanofi India, and the dividend history of Cadila Healthcare.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Gift Nifty Down 79 Points | Why Adani Group Stocks are Falling | Baazar Style Retail Files for IPO | Top Buzzing Stocks Today Gift Nifty Down 79 Points | Why Adani Group Stocks are Falling | Baazar Style Retail Files for IPO | Top Buzzing Stocks Today(Pre-Open)

On Monday, Indian share markets reversed the trend as the session progressed and ended the day higher.